Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Immunology - 1 Apr 2014

Verrall Ayesha J, Netea Mihai G, Alisjahbana Bachti, Hill Philip C, van Crevel Reimout

Abstract excerpt

Early clearance (EC) is the successful eradication of inhaled Mycobacterium tuberculosis before an adaptive immune response develops. Evidence for EC comes from case contact studies that consistently show that a proportion of heavily exposed individuals do not develop M. tuberculosis infection. Further support for the existence of this phenotype comes from genetic loci associated with tuberculin reactivity. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Load
Share to Coinfection
Share to Macrophages, Alveolar

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microbial Viability

Share to Phagocytosis

Share to T-Lymphocyte Subsets

Share to Tuberculosis

Share to Vitamin D Deficiency

Source

Open in PubMed Open full text

Identifiers

PMID: 24754048
DOI: 10.1111/imm.12223
PMCID: PMC3956425

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.PMID 24754048Read ↗

Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis?Semantic proximity Read ↗

Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells.Semantic proximity Read ↗

Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection.Semantic proximity Read ↗

Insights into protection against Mycobacterium tuberculosis infection: time to officially confirm another phenotype?Semantic proximity Read ↗

Immune profiling of <i>Mycobacterium tuberculosis</i>-specific T cells in recent and remote infectionSemantic proximity Read ↗

Host Immune Response to Mycobacterium tuberculosis Infection: Implications for Vaccine DevelopmentSemantic proximity Read ↗

Mycobacterium tuberculosis: Manipulator of Protective ImmunitySemantic proximity Read ↗

Specific CD4+ T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis.Semantic proximity Read ↗

Phenotype Definition for "Resisters" to Mycobacterium tuberculosis Infection in the Literature-A Review and Recommendations.Semantic proximity Read ↗

Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection.Semantic proximity Read ↗

Identification of Probable Early-Onset Biomarkers for Tuberculosis Disease ProgressionSemantic proximity Read ↗

Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.